Posted inBusiness Insights
Generic Drug Tariffs Threaten U.S. Healthcare Market, Warns Sandoz CEO
Sandoz CEO Richard Saynor warns that potential U.S. tariffs on imported generic drugs could increase patient costs and disrupt medication supply.
